Could be approved in two months.
And the Australian market won't let possible US approval for a novel therapy go by.
- Forums
- ASX - By Stock
- Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
Could be approved in two months.And the Australian market won't...
-
- There are more pages in this discussion • 303 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
98.5¢ |
Change
0.015(1.55%) |
Mkt cap ! $1.130B |
Open | High | Low | Value | Volume |
96.5¢ | 99.5¢ | 96.5¢ | $1.021M | 1.043M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
18 | 80254 | 98.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
98.5¢ | 25765 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
18 | 22249 | 0.985 |
16 | 105340 | 0.980 |
8 | 48402 | 0.975 |
11 | 122731 | 0.970 |
7 | 532735 | 0.965 |
Price($) | Vol. | No. |
---|---|---|
0.990 | 119507 | 30 |
0.995 | 273066 | 23 |
1.000 | 251599 | 23 |
1.010 | 17856 | 2 |
1.015 | 15000 | 1 |
Last trade - 11.37am 26/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online